News Column

Beijing Beilu Pharmaceutical Takes Stake in Geneseeq Tech

August 22, 2014

BEIJING, August 22, SinoCast -- Beijing Beilu Pharmaceutical Co., Ltd. (SZSE: 300016) revealed plans to purchase a 20% stake in Geneseeq Technology Inc. for CNY 30 million. Investment agreement has been inked between both sides.

Geneseeq Technology is set up by natural persons, engaged in developing, operating and selling gene detecting technology relating to cancer drugs.

Beijing Beilu Pharmaceutical harvested gross operating revenue of CNY 184 million in the first half of 2014, rising 19.82% from a year earlier. Net profit attributable to shareholders reached CNY 41.4936 million, hiking 26.72%.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters